356 related articles for article (PubMed ID: 17343573)
1. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004.
Wong HF; Low JJ; Chua Y; Busmanis I; Tay EH; Ho TH
Int J Gynecol Cancer; 2007; 17(2):342-9. PubMed ID: 17343573
[TBL] [Abstract][Full Text] [Related]
2. Epithelial ovarian tumors of borderline malignancy.
Chao TM; Yen MS; Chao KC; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
[TBL] [Abstract][Full Text] [Related]
3. Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors.
Jung HJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2020 Nov; 30(11):1780-1783. PubMed ID: 32928923
[TBL] [Abstract][Full Text] [Related]
4. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of 27 ovarian tumors of low malignant potential.
Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
[TBL] [Abstract][Full Text] [Related]
6. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
8. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
9. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
[TBL] [Abstract][Full Text] [Related]
11. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of borderline ovarian tumors: single center experience of 183 cases.
Gungor T; Cetinkaya N; Yalcin H; Ozdal B; Ozgu E; Baser E; Uygur D; Caglar M; Sirvan L; Erkaya S
Arch Gynecol Obstet; 2015 Jan; 291(1):123-30. PubMed ID: 25047273
[TBL] [Abstract][Full Text] [Related]
13. Borderline ovarian tumors.
Chambers JT; Merino MJ; Kohorn EI; Schwartz PE
Am J Obstet Gynecol; 1988 Nov; 159(5):1088-94. PubMed ID: 3189441
[TBL] [Abstract][Full Text] [Related]
14. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
15. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
16. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
17. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
[TBL] [Abstract][Full Text] [Related]
18. Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients.
Aggarwal A; Lucco KL; Lacy J; Kives S; Gerstle JT; Allen L
J Pediatr Surg; 2009 Oct; 44(10):2023-7. PubMed ID: 19853767
[TBL] [Abstract][Full Text] [Related]
19. Borderline epithelial ovarian tumors: a single center experience.
Numanoglu C; Ulker V; Kuru O; Akbayir O; Sakinci M; Akyol A
Eur J Gynaecol Oncol; 2014; 35(6):692-5. PubMed ID: 25556277
[TBL] [Abstract][Full Text] [Related]
20. Conservative management of epithelial ovarian cancer.
Dexeus S; Labastida R; Dexeus D
Eur J Gynaecol Oncol; 2005; 26(5):473-8. PubMed ID: 16285560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
